Current pattern of enteric fever: A prospective clinical and microbiological study

Journal of the Indian Medical Association

Volumn 105, Issue 10, 2007, Pages 582-591

  Verma, Madhoouka ^a   Parashar, Yogesh ^a   Singh, Anuradha ^a,b   Kamoji, Ravi ^a,b  

^a Holy Family Hospital   (India)

^b Department of Microbiology ^*

Author keywords

Antibiotic sensitivity; Enteric fever; Resistant; Typhoid

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; AZTREONAM; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; POLYSACCHARIDE VACCINE; QUINOLONE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; DISK DIFFUSION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; METHODOLOGY; PROSPECTIVE STUDY; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SALMONELLOSIS; TYPHOID FEVER;

EID: 39149109609     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Crump JA, Luby SP, Mintz ED - The global burden of typhoid fever. Bull World Health Organ 2004; 82: 346-53.
2. Parry CM, Hien TT, Dougan G, White NJ - Typhoid fever. N Engl J Med 2002; 347: 1770-82.
3. Mirza SH, Beeching NJ, Hart CA - Multi-drug resistant typhoid: a global problem. J Med Microbiol 1996; 44: 317-9.
4. Parry C, Wain J, Chinh NT, Vinh H, Farrar JJ - Quinolone-resistant Salmonella typhi in Vietnam. Lancet 1998; 351: 1289.
5. Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al - Typhoid fever in children less than 5 years. Lancet 1999; 354: 734-7.
6. National Committee for Clinical Laboratory Standards - Performance Standards for Antimicrobial Disk Susceptibility Tests (Approved Standard M2-A5), 1993. Vallinova: National Committee for Clinical Laboratory Standard, 1993.
7. Mahle WT, Levine MM - Salmonella typhi infection in children younger than five years of age. Pediatr Infect Dis J 1993; 12: 627-31.
8. Ivanoff B, Levine MM, Lambert PH - Vaccination against typhoid fever: present status. Bull World Health Organ 1994; 72: 957-71.
9. Brown JC, Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG - Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrob Chemother 1996; 37: 891-900.
10. Threlfall EJ, Ward LR, Skinner JA, Smith HR, Lacey S - Ciprofloxacin resistant Salmonella typhi and treatment failure. Lancet 1999; 353: 1590-1.
11. Vinh HA, Wain J, Vo TN, Cao NN, Mai TC, Bethell D, et al - Two or three days ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother 1996; 40: 958-61.
12. Schaad UB, abdus Salam M, Aujard Y, Dagan R, Green SD, Peltala H, et al - Use of fluroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995; 14: 1-9.
13. Sen S, Goyal RS, Dev R - Ciprofloxacin in the management of drug resistant typhoid fever. Indian Pediatr 1995; 62: 445-8.
14. Fujii R, Meguro H, Arimasu O, Ushijima K, Abe T, Nakazawa S, et al - Evaluation of norfloxacin in the pediatric field: Pediatric Study Group for Norfloxacin [Eng Abstr]. Jpn J Antibiot 1990; 43: 181-215.
15. Sood S, Kapil A, Das B, Jain Y, Kabra SK - Re-emergence of chloramphenicol-sensitive Salmonella typhi. Lancet 1999; 353: 1241-2.
16. Girgis NI, Butler T, French RW - Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999; 43: 1441-4.